Partnerships & Mergers

This initiative demonstrates a shared commitment to advancing preventive and personalized medicine, aligning with the UAE’s growing emphasis on healthspan, wellbeing, and healthcare innovation.

The partnership centers on incorporating Diagnoly’s Fetoly platform into GE HealthCare’s established Voluson women’s health ultrasound systems, marking a significant advancement in prenatal diagnostic technology.

The partnership merges Fujitsu Japan’s deep knowledge of the medical field and cutting-edge technologies, including artificial intelligence, with JMDC’s sophisticated prediction models derived from insurance user data.

Hetronifly is an anti-programmed cell death protein 1 (PD-1) monoclonal antibody that has already received regulatory approval in China for treating several solid tumor types.

Once the transaction successfully closes, the combined company plans to operate under the PrimeGen US name or through a successor entity.

The collaboration enables Sidra Medicine to connect Builders VC’s expertise and extensive network with their clinical teams, patient populations, and technological platforms.

The company plans to utilize two key facilities for this production: its Oxford, United Kingdom site and its Durham, North Carolina location.

The partnership builds on a Memorandum of Collaboration signed last year under the Global Oncology Initiative, which set the foundation for comprehensive cancer management improvements at the regional referral facility.

The acquisition encompasses MDCO’s complete portfolio of ophthalmic devices, including intraocular lenses (IOL), implantable contact lenses (Phakic Lens), and various refractive device platforms.

HC21 UK will showcase its capabilities at the ABHI UK Pavilion located in Hall 2, where members of its Irish management team will join forces to demonstrate the group’s comprehensive approach to market expansion.